$QNT

Morgan Stanley upgraded Quantinuum (QNT) to overweight with a $68 price target, citing its leadership in quantum error correction and execution. IonQ (IONQ) kept at equal-weight with a $43 target. Quantinuum leads in error correction, while IonQ has advantages in manufacturability and scalability. Both companies are key players in the quantum computing sector, with Morgan Stanley forecasting a $100B market by 2040.

Zilow Group (Z) and Quantinuum (QNT) each rose 11.05%, while Recursion Pharmaceuticals (RXRX) and Telefonaktiebolaget LM Ericsson (ERIC) gained 11.23% and 11.87%, respectively. Kyndryl Holdings (KD) climbed 11.87% after a deal with Toyota Group. Zilow and peers benefited from falling Treasury yields, while Morgan Stanley upgraded Quantinuum with a 69% upside target. Recursion partnered with Sanofi, and Ericsson reported better-than-expected Q3 earnings.

US futures decline as global AI sector selloff intensifies, with Korea's Kospi entering a bear market and CoreWeave bonds in distress. Anthropic's Q3 revenue growth slows, and Gartner warns of potential AI infrastructure impairment. Treasuries rally, with 10Y yields dropping 10bps to 5.08%. S&P 500, Nasdaq 100, and SOX indices fell yesterday. Premarket, Apple gains while other Mag-7 and AI-related stocks slide. Gold rises as AngloGold Ashanti is upgraded by Goldman Sachs.

Analysts upgraded several companies: Baird upgraded Bank of America (BAC) to Outperform with a $62 target, Deutsche Bank upgraded Walmart (WMT) to Buy with a $136 target, Morgan Stanley upgraded Quantinuum (QNT) to Overweight with a $62 target, Mizuho upgraded Array Technologies (ARRY) to Outperform with a $5 target, and Baird upgraded Zions Bancorporation (ZION) to Outperform with a $75 target.

Morgan Stanley upgraded Quantinuum (QNT) to Overweight with a $62 price target, citing its leadership in quantum computing technology. The stock trades near its 52-week low. QNT reported Q2 revenue of $8M, beating estimates, and projected $30M for 2026. Analysts from Mizuho, Yorkville Ives, and Bernstein SocGen maintained positive ratings with targets up to $95.

Quantinuum (QNT), IBM (IBM), and Nvidia (NVDA) are highlighted as quantum computing stocks with potential. Quantinuum, backed by Honeywell, is a newcomer with trapped-ion technology. IBM is investing $10B for a 2029 quantum breakthrough. Nvidia provides quantum-classical computing integration. All three are positioned for growth in the quantum sector.

Quantum computing stocks like IONQ, QBTS, RGTI, and QUBT fell sharply on Wednesday due to rising U.S. Treasury yields, which increased borrowing costs and affected valuations of speculative tech companies. The 10-year Treasury yield briefly hit 5.36%, its highest since 2002. IonQ announced a $300 million DARPA agreement after market close, unrelated to the day's decline.

Quantinuum Inc. filed a joint ownership report showing Citadel entities and Kenneth Griffin may beneficially own 7.3% of its Class A common stock, with shared voting and dispositive power. The report is based on 32,862,895 shares outstanding as of June 5, 2026, according to the company's prospectus.

Quantinuum (QNT) and The University of Western Australia (UWA) have partnered to advance quantum research and workforce training in Australia. The collaboration provides UWA with access to Quantinuum's quantum ecosystem, including its 98-qubit Helios system, to develop hybrid quantum-AI-HPC workflows for key economic sectors. The agreement also explores establishing a quantum computing applications center at UWA.

Quantinuum (QNT) partnered with the University of Australia to advance quantum computing. The company's P/S ratio is 126x, below its historical median, and it has a GF Score of 14. Insiders have bought $24.7M in shares. QNT is unprofitable but shows strong financial strength.